Tris[2-(tetrazol-5-yl)ethyl]nitromethane, the first example of a branched polynuclear tetrazole system

被引:0
|
作者
Zubarev, V.Yu. [1 ]
Ostrovskii, V.A. [1 ]
机构
[1] St. Petersburg State Technological Institute, St. Petersburg 198013, Russia
关键词
D O I
10.1007/BF01176978
中图分类号
学科分类号
摘要
5
引用
收藏
相关论文
共 50 条
  • [41] Hydrothermal syntheses, crystal structures and physical properties of a new family of energetic coordination polymers with nitrogen-rich ligand N-[2-(1H-tetrazol-5-yl)ethyl]glycine
    Wang, Shuai-Hua
    Zheng, Fa-Kun
    Wu, Mei-Feng
    Liu, Zhi-Fa
    Chen, Jun
    Guo, Guo-Cong
    Wu, A-Qing
    CRYSTENGCOMM, 2013, 15 (14): : 2616 - 2623
  • [42] Discovery of a novel sub-class of ROMK channel inhibitors typified by 5-(2-(4-(2-(4-(1H-Tetrazol-1-yl)phenyl)acetyl)piperazin-1-yl) ethyl)isobenzofuran-1(3H)-one
    Tang, Haifeng
    de Jesus, Reynald K.
    Walsh, Shawn P.
    Zhu, Yuping
    Yan, Yan
    Priest, Birgit T.
    Swensen, Andrew M.
    Alonso-Galicia, Magdalena
    Felix, John P.
    Brochu, Richard M.
    Bailey, Timothy
    Thomas-Fowlkes, Brande
    Zhou, Xiaoyan
    Pai, Lee-Yuh
    Hampton, Caryn
    Hernandez, Melba
    Owens, Karen
    Roy, Sophie
    Kaczorowski, Gregory J.
    Yang, Lihu
    Garcia, Maria L.
    Pasternak, Alexander
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (21) : 5829 - 5832
  • [43] A REAGENT, ETHYL 2-(2-TERT-BUTYL-2H-TETRAZOL-5-YL)-3-(DIMETHYLAMINO)ACRYLATE (DMTE), FOR FACILE SYNTHESIS OF 2,3-(RING FUSED)-5-(5-TETRAZOLYL)-4H-PYRIMIDIN-4-ONE DERIVATIVES
    KANNO, H
    YAMAGUCHI, H
    ICHIKAWA, Y
    ISODA, S
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1991, 39 (05) : 1099 - 1105
  • [44] Biomolecular docking, synthesis, crystal structure, and bioassay studies of 1-[4-(2-chloroethoxy)phenyl]-5-[4-(methylsulfonyl) phenyl]-1H-tetrazole and 2-(4-(5-(4-(methylsulfonyl)phenyl)-1H-tetrazol-1-yl)phenoxy)ethyl nitrate
    Al-Hourani, Baker Jawabrah
    El-Barghouthi, Musa, I
    Al-Awaida, Wajdy
    McDonald, Robert
    Fattash, Isam A.
    El Soubani, Fatima
    Matalka, Khalid
    Wuest, Frank
    JOURNAL OF MOLECULAR STRUCTURE, 2020, 1202
  • [45] New approach to the synthesis of tetrazole-containing buta-1,3-diynes: The total synthesis of 1,4-bis(2-(tert-butyl)-2H-tetrazol-5-yl)buta-1,3-diyne
    Belousov, George K.
    Zuraev, Alexander, V
    TETRAHEDRON LETTERS, 2019, 60 (45)
  • [46] Effects of the new angiotensin receptor antagonist dipotassium (Z)-2-[[5-ethyl-3-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl-1,3,4-thiadiazoline-2-ylidene]aminocarbonyl]-1-cyclopentencarboxylate on experimental cardiac hypertrophy and acute left ventricular failure
    Murakami, M
    Inada, Y
    Tazawa, S
    Nakao, K
    Komatsu, H
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1997, 47 (10): : 1099 - 1103
  • [47] First (peroxo)vanadium(v) complex with heteroligand formed in reaction system -: Synthesis, structure and reactivity of K[VO(O2)(omeida)]•-H2O{omeida = N-[2-(2-oxomorpholine-4-yl)ethyl]iminodiacetato(2-)}
    Sivák, M
    Mad'arová, M
    Tatiersky, J
    Marek, J
    EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2003, (11) : 2075 - 2081
  • [48] SYNTHESIS OF 1-([1-C-14]CYCLOHEXYLOXYCARBONYLOXY)ETHYL 7-BETA-[2-(2-AMINOTHIAZOL-4-YL)ACETAMIDO]-3-[[[1-(2-DIMETHYLAMINO-ETHYL)-1H-TETRAZOL-5-YL]THIO]METHYL]CEPH-3-EM-4-CARBO-XYLATE DIHYDROCHLORIDE ([C-14]SCE-2174)
    WATANABE, M
    TADA, N
    IMANISHI, M
    YAMAOKA, M
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1988, 25 (03): : 257 - 261
  • [49] Simultaneous LC-MS-MS Determination of HM30181A, [2-(2-{4-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl}-2H-tetrazol-5-yl)-4,5-dimethoxyphenyl]amide, as a new P-Glycoprotein Inhibitor and Its Two Metabolites, M1 and M2, in Human Plasma: Application to a Pharmacokinetic Study
    Choi, Young Hee
    Oh, Seul
    Yoon, Seo-Hyun
    Kim, Tae-Eun
    Gu, Namyi
    Kim, Eun Young
    Kim, Han Kyong
    Yu, Kyung-Sang
    Jang, In-Jin
    Shin, Sang-Goo
    Cho, Joo-Youn
    CHROMATOGRAPHIA, 2011, 73 (3-4) : 273 - 280
  • [50] Simultaneous LC–MS–MS Determination of HM30181A, [2-(2-{4-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl}-2H-tetrazol-5-yl)-4,5-dimethoxyphenyl]amide, as a new P-Glycoprotein Inhibitor and Its Two Metabolites, M1 and M2, in Human Plasma: Application to a Pharmacokinetic Study
    Young Hee Choi
    Seul Oh
    Seo-Hyun Yoon
    Tae-Eun Kim
    Namyi Gu
    Eun Young Kim
    Han Kyong Kim
    Kyung-Sang Yu
    In-Jin Jang
    Sang-Goo Shin
    Joo-Youn Cho
    Chromatographia, 2011, 73 : 273 - 280